Try our beta test site
62 studies found for:    alogliptin
Show Display Options
Rank Status Study
1 Not yet recruiting Safety and Efficacy of Alogliptin in Indian Participants With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Alogliptin
2 Completed
Has Results
Pharmacokinetics, Pharmacodynamics, and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Alogliptin
3 Completed
Has Results
Long-term Safety of Alogliptin in Patients With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus
Intervention: Drug: Alogliptin
4 Completed Alogliptin/Pioglitazone (Liovel) Liovel Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Alogliptin/pioglitazone
5 Recruiting Phase 3 Alogliptin Pediatric Study
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Alogliptin Benzoate;   Drug: Placebo
6 Recruiting Local, Multicenter, Observational, Non-Interventional Prospective Study of Alogliptin Benzoate in Participants With Diabetes Mellitus Type 2
Condition: Diabetes Mellitus
Intervention: Drug: Alogliptin Benzoate
7 Completed
Has Results
Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome
Conditions: Diabetes Mellitus, Type 2;   Acute Coronary Syndrome
Interventions: Drug: Alogliptin;   Drug: Placebo
8 Recruiting Alogliptin Tablets Specified Drug-use Survey "Type 2 Diabetic Patients Receiving Combination Therapy With a Hypoglycemic Agent (e.g., Insulin Preparations or Rapid-acting Insulin Secretagogues)"
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Alogliptin
9 Completed
Has Results
Long-term Study of Alogliptin as an Add-on to Rapid-Acting Insulin Secretagogues in Type 2 Diabetes
Condition: Diabetes Mellitus
Interventions: Drug: Alogliptin;   Drug: Rapid-acting insulin secretagogue
10 Completed
Has Results
Pharmacokinetics and Pharmacodynamics Study of Alogliptin in Healthy Korean Participants
Condition: Pharmacokinetics and Pharmacodynamics
Intervention: Drug: Alogliptin
11 Recruiting Non-Interventional Study of the Use of Alogliptin and Alogliptin Fixed-Dose Combinations With Pioglitazone and With Metformin in Standard Clinical Practice
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Alogliptin;   Drug: Alogliptin FDC With Pioglitazone;   Drug: Alogliptin FDC With Metformin
12 Recruiting An Exploratory Study to Evaluate the Effects of Trelagliptin and Alogliptin by CGM on Glucose Variability for One Week With Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Trelagliptin;   Drug: Alogliptin
13 Completed
Has Results
Long-term Safety Study of Alogliptin Used in Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Alogliptin and pioglitazone
14 Completed
Has Results
Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Diabetics
Condition: Diabetes Mellitus
Interventions: Drug: Alogliptin;   Drug: Glipizide
15 Completed Study of Combination Therapy With SYR-322
Condition: Diabetes Mellitus
Interventions: Drug: Alogliptin;   Drug: Insulin
16 Active, not recruiting Alogliptin Tablets Special Drug Use Surveillance: Mild Type 2 Diabetes Mellitus
Condition: Surveillance
Intervention: Drug: Alogliptin
17 Completed
Has Results
Long-term Safety Study of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Alogliptin and voglibose
18 Completed Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Biguanides
Condition: Surveillance
Intervention: Drug: Alogliptin
19 Completed Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Sulfonylurea
Condition: Surveillance
Intervention: Drug: Alogliptin
20 Completed Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Monotherapy/Combination Therapy With α-GI"
Condition: Patients With Type 2 Diabetes Mellitus Who Have Been Examined at a Medical Institution
Intervention: Drug: Alogliptin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.